Animal Genetics Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2032

 

Overview:

The Global Animal Genetics Market Share is projected to reach at a CAGR of 6.9% during the forecast period 2023-2032. Market Research Future (MRFR) identifies 2018 to 2023 as the forecast period. The market is known for its intense coverage of the study of genetic variation and inheritance. This includes primarily for domestic and wild animals. Animal genetics includes several sides like genetic disease testing, DNA typing, and genetic trait testing that can benefit diverse industries. This method mostly tries to determine the state of diseases in various animals owing to which the consumption of animal products may get affected. 

Major influencer impacting the intake of animal genetics is the rising consumption of animal-derived protein, which gets bolstered by booming population and rapid urbanization. The need for the superior breed is also emerging as a decisive factor for the market. This can also boost the toxicology market. But the high cost of these testing can impact the global market growth. The stringent regulatory framework can also play a crucial role in holding back the normal growth rate.  Lack of skilled professionals can also deter the market from having its normal growth structure.

Competitive Landscape:

Global Animal Genetics Market Players making influential contributions to the market are URUS (US), Neogen Corporation (US), Genus (UK), Groupe Grimaud (France), EW Group (Germany), Topigs Norsvin (Netherlands), CRV Holding B.V. (The Netherland), vetGen (US), Hendrix Genetics BV (The Netherland), Zoetis (US), Envigo (US), Alta Genetics (US), Animal Genetics (US), and others. These players are known for their extensive contributions to developing the market dynamics that can impact the global market scenario. MRFR’s profiling is expected to bring out insights regarding how the market may shape up.

Segmentation:
The Global Animal Genetics Market Outlook, as per the report, has been segmented with a strong foundation in services, animal genetic products, and end-user. This segmentation is targeting specific details with the potential of triggering the growth rate in the coming years.

By animal genetic products, the market report considers the animal genetics market upon segmenting it into genetic materials and live animals. The live animals segment includes bovine, porcine, canine, poultry, and others. The genetic materials have been further segmented into semen and embryo.

By services, the animal genetics market report covers gene trait tests, DNA typing, genetic disease tests, and others. These segments are finding it easier to percolate the research industry as they offer a better grip on the data.

By the end-user, the market for animal genetics market has been segmented into research centers & institutes, diagnostic centers, veterinary hospitals & clinics, and others. The research centers & institutes can inspire growth.

Regional Market

The Americas have the chance to lead the market as the region is witnessing a strong surge in its investment sector. The regional market is known for its high intake of animal protein through various types of animal products owing to which companies are investing much in developing strategies for the research and development sector. It is getting further traction from the hike in the speed of urbanization, which is transforming lives and creating more opportunities for the market to permeate. Increasing artificial insemination in animals like pigs, sheep, cattle, and goats can fuel growth. In Europe, the regional market can exploit the favorable market dynamics and ensure strong growth for itself. The rise in genetic diseases can make sure the research sector spends more money to score well in the coming years.

The Asia Pacific market has placed itself as a country that can grow with the fastest CAGR during the forecast period. This can benefit from the growing population of livestock and the inclusion of advanced DNA typing and genetic testing tools that inspires better testing facilities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Biologic Therapy Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2030

 

Global Biologic Therapy Market to Grow Healthily over 2023

Biologic therapy is gaining traction. According to a report published by Market Research Future (MRFR), the global biologic therapy market share is set to reach USD 288.03 billion by 2030 at a CAGR 8.20% over the forecast years 2023-2030. Biologic therapy is viewed as an innovative treatment module based on products sourced from living organisms.

Biologic therapy is used to stimulate or suppress the immune system for treatment purposes. The therapy finds application in treatment of diseases such as infection, cancer and several other diseases. Advances in the field of biologic therapeutic is boosting the application scope of biologic therapy. Rising demand for biological and targeted drug therapies is making a positive impact on the global biological therapy market. The R&D pipeline for biologic therapy is expected to grow in the future as pharmaceutical companies realise the vast market opportunities. 

Global Biologic Therapy Market: Competition Analysis

Global biologic therapy market players include Bristol-Myers Squibb, Amgen Inc., Eli Lilly, Seattle Genetics, Inc., GlaxoSmithKline Plc., Novartis International AG, Celgene Corporation and Spectrum Pharmaceuticals, Inc.

Global Biologic Therapy Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on therapy, product type, end-user and application. Based on therapy, the market has been segmented into vaccines therapy, cell therapy, protein therapy and others. Based on product type, the market has been segmented into services, instruments and kit and reagents. Based on end-user, the market has been segmented into hospitals and clinic, research centers and speciality centers. Based on application, the market has been segmented into blood and blood-related products testing, tissue and tissue-related products testing, vaccine and therapeutics development, stem cell research and cellular and gene therapy.

Global Biologic Therapy Market: Regional Analysis

On the basis of region, the biologic therapy market insights has been segmented into North America, Europe, the Middle East & Africa (MEA), Latin America and Asia Pacific (APAC). North America represents an important market for biologic therapy. Rising geriatric population, growing cancer prevalence in countries such as the U.S. and Canada are some of the factors supporting the market growth in the region. Data released by United States Census Bureau reveals that the total count of Americans aged 65 and above surpassed 49.2 Mn in 2016. Advanced countries in North America have robust health coverage policies along with a quicker access to latest biologic therapeutics. Many market players operating in North America are focusing on patient-centric products. In addition, companies are focusing on delivering customized therapeutics. High healthcare spending in the region is also influencing the market growth. The Center for Disease Control and Prevention reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.

Europe in hold the second spot in the global biologic therapy market outlook in terms of revenue. The market in Europe is expected to exhibit a healthy growth over the next couple of years. The healthcare sector remains focused on innovation and continue to excel in delivering quality care. In addition, presence of an advanced healthcare system is reflecting favourably on the market in the region. Many of the advanced countries in Europe have large pool of geriatric population. Data released by Eurostat revealed that more that 19% of the over population in Europe is aged 65 and above.

Asia Pacific is emerging as a highly attractive market for biologic therapy. It is projected that the market in APAC will demonstrate the fastest growth during the forecast period. Increased occurrence of lifestyle diseases is driving the demand for biologic therapy. Rising healthcare expenditure, increased awareness level and improving healthcare infrastructure are some of the key factors influencing the market in APAC.

The market in MEA is expected to witness a relatively slower growth during the forecast period. This is mainly owing low penetration and limited access. However, increased efforts towards improving healthcare standard in GCC countries is likely to create market opportunities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Robot-Assisted Surgical Systems Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2032

 

Market Overview

It is projected that the global robot-assisted surgical system market share is projected to reach at a CAGR 16.5% During the forecast period 2023-2032. Medical robotics technology is undergoing a tremendous transformation. Advancements in various fronts are being observed, which is providing an impetus to the application potential of healthcare robotics. The arrival of 3D imaging, HD surgical microscopic cameras, robotic catheter control system (CCS), data recorders & data analytics and remote navigation has enabled the undertaking of highly complex surgical produces.

The growing need for high surgical accuracy is driving the adoption of robot-assisted surgical systems. Moreover, an increased number of surgical procedures due factors such as a higher prevalence of trauma injuries, and rising geriatric population. Healthcare robotics boasts a strong R&D pipeline, which indicates towards a brighter future. Companies are actively focusing on devloping innovative products and their fast commercialization. For instanace, the US FDA approved Intuitive Surgical’s the da Vinci SP surgical system, which can be used in critical urologic surgical procedures in May 2018. However, the path is not without hurdles, high cost of such devices market customer pool limited. Product penetration remains sluggish in price-sensitive markets.

 

Global Robot-Assisted Surgical Systems Market: Competition Analysis

The Robot-Assisted Surgical Systems Market Players are Renishaw Plc, Stryker Corporation (MAKO Surgical Corp.), Accuracy, Health Robotics S.R.L.,Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Medtronic plc, Zimmer Biomet Holdings Inc., Verb Surgical,Titan Medical, Microbot Medical, Varian, Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Transenterix, KUKA AG, Medrobotics, Intuitive Surgical Inc, THINK Surgical Inc., and Mazor Robotics are among the key companies profiled in MRFR’s report.

 

Global Robot-Assisted Surgical Systems Market: Segmental Analysis

The segmental analysis of the global robot-assisted surgical systems market outlook has been conducted on the basis of end user, product, and application.

On the basis of end user, the market has been segmented into healthcare payers, healthcare providers and others. Based on product, the market has been segmented into rehabilitation robots, hospital and pharmacy robots, emergency response robotic systems, surgical robots and non-invasive radiosurgery robots. The rehabilitation robots segment covers prosthetics, therapeutic robots, robotic exoskeleton systems, orthotics and assistive robots. The hospital and pharmacy robots segment covers IV robots, cart transportation robots, pharmacy robots and telemedicine robots. The surgical robot segment covers laparoscopy robotic systems, robotic neurosurgical systems, and orthopedic surgical robots. Categories of laparoscopy robotics systems include Da Vinci robotic surgery system, Steerable Robotic Catheters, FreeHand endoscope holder system and Telelap ALF-X surgical system. Categories of robotic neurosurgical systems include NeuroMate surgical system, Renaissance surgical system and Pathfinder surgical system. Categories of orthopedic surgical robots include Robodoc surgical system, iBlock surgical system, MAKO RIO surgical system, Stanmore Sculptor surgical system and Navio PFS surgical system. On the basis of application, the market has been segmented into orthopedics robotic systems, special education, laparoscopy and neurology.

 

Global Robot-Assisted Surgical Systems Market: Regional Analysis

The regional analysis of the robot assisted surgical market insights has been conducted across the Middle East and Africa (MEA), Asia Pacific (APAC), Europe, and the Americas. In MEA, the market has been assessed in GCC countries and Africa. In APAC, countries such as China, Japan, India, South Korea, Australia, among others are covered. In the report, the Europe market has been segmented into Western and Eastern Europe. In West Europe, countries such as Germany, France, Italy, Spain, and the UK were under the spotlight. The Americas market has been segmented into Latin America and North America. In North America, the U.S. and Canada are covered.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Tumor Ablation Market Share Expected to reach a notable valuation by 2032

 

Market Analysis

The global tumor ablation market share is projected to reach at a stellar 11.8% CAGR during the forecast period (2023-2032). Tumor ablation is a technique that is minimally invasive and commonly used for treating tumors in the lung, bone, kidney and liver. During this process, thermal energy is utilized to cool or heat tissues to cytotoxic levels. Under its classification, there are various modalities used worldwide: irreversible electroporation, cryoablation, high-intensity focused ultrasound, laser, microwave and radiofrequency. Every technique though similar in purpose possess optimal and specific indications. Tumor ablation is a vital choice for those who have failed radiotherapy or chemotherapy or is not a candidate for surgery. It is also considered as the potential first-line treatment especially in patients with benign tumors in the liver or small hepatocellular carcinomas. This is a convenient and excellent treatment choice over the other conventional surgical methods.

There are several factors that is propelling the growth of the tumor ablation market. These factors according to MRFR (Market Research Future) report include rapid adoption of novel form of treatment for fighting cancer, growing public awareness programs for detecting cancer at the initial stage, funds offered by the government for cancer research, extensive use of minimally invasive methods due to its myriad benefits such as minimal complications, less trauma and speedy recovery, rising per capita income and various technological advancements such as HIFU (High-Intensity Focused Ultrasound), irreversible electroporation, laser ablation and thermal ablation. On the contrary, factors such as exorbitant price of tumor ablation methods, constraint subsidy scenarios, dearth of experts and strict regulations for product approval may restrain the growth of the tumor ablation market.

Key Players

Tumor ablation market players include Covidien PL, Misonix Inc., Galil Medical, Inc, Biotronik, Boston Scientific Corporation, Neuwave Medical, Inc., Healthtronics Inc., AngioDynamics Inc., EDAP TMS, Medtronic Plc., and SonaCare Medical.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market outlook on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Regional Analysis

By region, the tumor ablation market insights growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Herbal Medicinal Products Market Share accelerating a CAGR during the forecast period 2023-2032

 

Market Insights

Herbal medicinal products are medicinal products which have been prepared using plant or other natural sources. Herbal plants have a number of medically relevant natural ingredients which can be used in the production of dietary supplements, ointments and a variety  of other medical products. Market Research Future has performed a detailed study regarding the growth of the herbal medicinal products market share is anticipated to grow USD 21.01 billion by 2032 at a healthily CAGR of 12.2 % over the assessment period from 2023 to 2032.

Due to urbanization and the adoption of busy lifestyles, chronic diseases and other lifestyle problems are at an all-time high. Consumers are increasingly becoming health conscious and aware regarding various vital ingredients in medicine and food products. As a result, increasing consumer demand has been witnessed for green label products that are largely composed of natural ingredients. Moreover, allopathic medicine famously uses synthetic chemicals and other ingredients which can cause side effects. The growing awareness regarding these ill effects of allopathic medicine is expected to drive the growth of the herbal medicinal products market insights. Although it is recommended that consumers consult their doctor before consumption of any medically relevant products, herbal medical products are often very safe to take and do not require a prescription. In certain parts of the world, traditional herbal medicine is still embraced, driving consistent demand. Additionally, there is a low processing cost associated with herbal medicinal products which are also expected to boost market growth over the assessment period.

Notably, the market's growth is hindered by the lack of government support for the promotion of herbal medicinal products. The presence of market players who promote herbal medicinal products which are untested and have no medicinal value is also expected to challenge market growth. However, R&D activities regarding herbal ingredients will likely mitigate some challenges and prove the market with room to grow.

Key Players

Herbal Medicinal Products Market players are included in

Young Living Essential Oils LC (U.S.), ARKOPHARMA Laboratories Company Ltd. (France), Nature's Answer, Inc. (U.S.), TSUMURA & CO. (Japan), Ricola AG (Switzerland), Bio-Botanica Inc. (U.S.), and Sanofi-Aventis Healthcare Pty Ltd. (Australia) are the more prominent market participants in the global herbal medicinal products market. MRFR has identified and recorded pertinent information regarding these players competitive roles in the market.

Market Segmentation

The global herbal medicinal products market outlook has been segmented on the basis of type, function, form, and region. Types of herbal medicinal products have been segmented into homeopathic medicines, traditional Chinese medicines, aromatherapy medicines, ayurvedic medicines, and others. Ayurvedic medicines possess the largest share of the market, and the segment is followed by Chinese medicine. Ayurvedic formulations are in high demand are often easily approved for distribution by the relevant regulatory authorities. 

Function has been segmented to include  cardiovascular health, general wellness, gut & digestive health, cognitive health, and others. Gut and digestive health is the dominating segment among the mentioned segments. The increasing demand and use of herbal medicinal products for digestive problems are expected to drive the market. Herbal medicines for cardiovascular health have been witnessed to have a growing demand.

Forms of herbal medicinal products have been segmented into syrups, powder, ointments, capsules, tablets, oils, and others. Tablets lead the market and are followed by capsules as they deliver the ideal dosage of herbal medicinal ingredients . Tablets and capsules are also easy to store and carry.

Regional Analysis

MRFR has covered regions such as Asia Pacific, Europe, North America and Rest of the World. Europe leads the market with the largest share and is followed by the Asia Pacific regional market. Europe has been observed to be having the highest consumption and demand for herbal medicinal products. The rising awareness regarding herbal ingredients and the support of relevant government bodies for new product launches will likely be key in the region's growth. Meanwhile, the APAC is growing rapidly due to the high adoption of products which include herbal ingredients. Country-level markets such as India and China are the birthplaces of ayurvedic medicine and Chinese medicine respectively. As such the region has an affinity toward the adoption of herbal medicinal products over allopathic medicinal products.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Enteral Feeding Devices Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2032

 

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·         By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·         On the basis of age group, the market has been divided into adults and pediatrics. 

·         By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·         Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013                

Corporate Wellness Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2030

 

Market overview

The global corporate wellness market share is estimated to exhibit growth by expanding at 8.5% during the forecast period 2022-2030 to reach a valuation of USD 114.4 billion by 2030. This growth is attributable to the higher acceptance of corporate wellness programs, which are designed to evaluate the employee’s health.

Additionally, these wellness programs are designed to estimate the probable health risks and promote healthy behavior at the workplace. Thus, these programs promote a healthy environment at workplaces and enhance productivity by lower healthcare spending substantially. Such factors are driving growth of the global corporate wellness market.

Further, the adoption of such programs results in improve morale & quality of work and decreases absenteeism; thus, several organizations are adopting corporate wellness programs. Rising prevalence of obesity, smoking, alcoholism, and other chronic diseases among white-collar workers especially in the private sector are boosting the adoption of corporate wellness. According to the data by the World Health Organization (WHO), more than 1.1 billion people were smoking tobacco in 2015. Additionally, the prevalence of obesity has tripled from the past three decades. Such data are reflecting the need for the adoption of corporate wellness programs among employers to keep their employees healthy to deliver quality work on time. This is a key factor estimated to drive growth of the global corporate wellness market in the coming years.

Competitive Analysis:

The global corporate wellness market players include ComPsych Corporation, SOL Wellness, Wellness Corporate Solutions, LLC, Wellsource, Inc., Truworth Health Technologies Pvt. Ltd., Central Corporate Wellness, Virgin Pulse, EXOS, Marino Wellness, Privia Health, ProvantHealth (Hooper Holmes, Inc.), The Vitality Group, Inc., Sodexo Group, and Bupa Wellness Pty Ltd.

Segmentation:

The global corporate wellness market outlook has been segmented into category, service type, end user, and region.

By service type, the market is segmented into stress management, health risk assessment, nutrition & weight management, fitness, smoking cessation, health screening, and others. Of these, the health risk assessment segment dominated the global corporate wellness market in 2017 owing to the increasing adoption of wellness programs for wellbeing and assessment of health risks of employees. Additionally, implementation of the appropriate intrusion strategies and promotion of adopting a healthy lifestyle are benefiting the segmental growth.

On the basis of category, the market is segmented into psychological therapists, fitness & nutrition consultants, and organizations.

Based on end users, the market is segmented into medium-scale businesses, small-scale businesses, and large-scale businesses.

Regional Analysis:

Regionally, the corporate wellness market insights is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, North America dominated the global corporate wellness market in 2017 and is estimated to remain dominant during the forecast period owing to the presence of corporate wellness program providers coupled with a substantial increase in the prevalence of chronic diseases in the region. Additionally, the most significant expenditure on healthcare in the region and surge in the adoption of wellness activities in Canada and the U.S.

Further, Europe is likely to hold the second-largest share in the revenue of the corporate wellness market owing to the increasing activeness of European employees and employers. Additionally, corporate wellness programs are increasingly taking a crucial part of medium or large organizations in the region, which is augmenting the growth of the market. The corporate wellness programs have become the strategic priority in European organizations; thus, the market in the region is flourishing continuously. However, the market in the Asia Pacific is estimated to expand by exhibiting a faster CAGR owing to robust industrialization and urbanization in the region. In addition to this, the increasing awareness about the health of employees due to the effects of long working hours and larger workload in countries such as India and China are estimated to benefit the market growth in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America